Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAkari Therapeutics, Plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$1.00 | -$1.00 | -$1.00 |
| Q2 2024 | 1 | -$0.60 | -$0.60 | -$0.60 |
| Q3 2024 | 1 | -$1.00 | -$1.00 | -$1.00 |
Akari Therapeutics, Plc Earnings Date And Information
Akari Therapeutics, Plc last posted its earnings results on Tuesday, November 19th, 2024. The company reported $-0.23743 earnings per share for the quarter, topping analysts' consensus estimates of $-0.6 by $0.36257. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Akari Therapeutics, Plc has generated $-2 earnings per share over the last year ($-2.04 diluted earnings per share) and currently has a price-to-earnings ratio of -0.61. Akari Therapeutics, Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 4th, 2025 based on prior year's report dates.
Akari Therapeutics, Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/19/2024 | Q3 2024 | -$0.60 | -$0.24 | 0.36 | $0 | $0 |
| 08/19/2024 | Q2 2024 | -$0.80 | $0 | $0 | ||
| 03/29/2024 | Q1 2024 | -$0.83 | $0 | |||
| 12/30/2023 | Q4 2023 | -$0.65 | $0 | |||
| 09/28/2023 | Q3 2023 | -$0.65 | $0 | |||
| 09/29/2023 | Q2 2023 | -$1.00 | -$0.68 | 0.32 | $0 | |
| 09/29/2023 | Q1 2023 | -$1.00 | $0.27 | 1.27 | $0 | |
| 12/30/2022 | Q4 2022 | -$1.01 | $0 | |||
| 07/20/2022 | Q3 2022 | -$1.01 | $0 | |||
| 05/17/2022 | Q2 2022 | -$0.09 | $0 | |||
| 05/17/2022 | Q1 2022 | -$0.10 | $0 | |||
| 12/03/2021 | Q4 2021 | -$0.12 | $0 | |||
| 12/03/2021 | Q3 2021 | -$0.03 | $0 | |||
| 04/20/2021 | Q2 2021 | -$0.11 | $0 | |||
| 04/20/2021 | Q1 2021 | -$3.04 | $0 | |||
| 12/11/2020 | Q4 2020 | -$5.19 | $0 | |||
| 12/11/2020 | Q3 2020 | $0.54 | $0 | |||
| 03/31/2020 | Q2 2020 | -$5.54 | $0 | |||
| 03/31/2020 | Q1 2020 | -$2.69 | $0 | |||
| 11/27/2019 | Q4 2019 | -$7.30 | $0 |
Akari Therapeutics, Plc Earnings: FAQ's
When is Akari Therapeutics, Plc's earnings date?
Akari Therapeutics, Plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 4th, 2025 based off last year's report dates.
Did Akari Therapeutics, Plc beat their earnings estimates last
quarter?
In the previous quarter, Akari Therapeutics, Plc (:AKTX) reported $-0.23743 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.6 by $0.36257.
How can I listen to Akari Therapeutics, Plc's earnings conference
call?
The conference call for Akari Therapeutics, Plc's latest earnings report can be listened to online.
How can I read Akari Therapeutics, Plc's conference call transcript?
The conference call transcript for Akari Therapeutics, Plc's latest earnings report can be read online.
How much profit does Akari Therapeutics, Plc generate each year?
Akari Therapeutics, Plc (:AKTX) has a recorded net income of $0. Akari Therapeutics, Plc has generated $-2.04 earnings per share over the last four quarters.
What is Akari Therapeutics, Plc's price-to-earnings ratio?
Akari Therapeutics, Plc (:AKTX) has a price-to-earnings ratio of -0.61 and price/earnings-to-growth ratio is -0.04.